Skip to content

Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications

Treatment of Radiation-Induced Complications With Hyperbaric Oxygen Therapy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07422168
Enrollment
39
Registered
2026-02-19
Start date
2016-05-19
Completion date
2019-12-31
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation Injury, Radiation-Induced Complications, Radiation Necrosis

Keywords

Hyperbaric oxygen therapy, HBOT

Brief summary

This study evaluates the safety and effectiveness of hyperbaric oxygen therapy (HBOT) for the treatment of severe radiation-induced complications in patients previously treated with radiotherapy. Patients with clinically significant late radiation injuries will undergo HBOT sessions in a hyperbaric chamber. The study aims to assess clinical improvement of radiation damage and overall treatment tolerance.

Detailed description

Radiotherapy can cause severe late complications such as tissue necrosis, impaired wound healing, radiation cystitis, radiation proctitis, and other chronic radiation-induced injuries. These conditions may significantly reduce quality of life and can be difficult to treat with standard therapies. Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen under increased atmospheric pressure in a hyperbaric chamber. This increases tissue oxygenation, supports angiogenesis, improves wound healing, and may reduce symptoms associated with radiation injury. This prospective interventional study will include patients with severe radiation-induced complications referred for HBOT at the Institute of Oncology Ljubljana. Participants will undergo a series of HBOT sessions according to institutional protocol. Clinical outcomes will be documented and analyzed to evaluate treatment effectiveness and safety. Data will be collected prospectively and statistically analyzed to assess the degree of symptom improvement and the occurrence of adverse events related to HBOT.

Interventions

Participants will undergo hyperbaric oxygen therapy sessions in a hyperbaric chamber, breathing 100% oxygen under increased atmospheric pressure, according to institutional protocol, to treat severe radiation-induced complications and support tissue healing.

Sponsors

Institute of Oncology Ljubljana
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (≥18 years) * History of radiotherapy * Clinically significant radiation-induced complications requiring hyperbaric oxygen therapy * Ability to provide written informed consent

Exclusion criteria

* Contraindications to hyperbaric oxygen therapy (e.g., untreated pneumothorax) * Severe comorbidity preventing safe HBOT treatment * Inability to tolerate hyperbaric chamber sessions * Withdrawal of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Reduction of severe radiation-induced tissue damageUp to 3 months after completion of HBOT treatmentClinical Improvement of Radiation-Induced Complications After HBOT

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026